Berlin, June 19 (CNA) French microbiologist Emmanuelle Charpentier, who was named a co-winner of the second Tang Prize in biopharmaceutical science on Sunday for her work in the development of CRISPR/Cas9, said she hopes the genome editing technology can be used to treat currently incurable conditions.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan reports one new domestic COVID-19 case from hospital
01/16/2021 11:31 PM - Sports
Taiwan shuttlers reach finals at Yonex Thailand Open
01/16/2021 10:33 PM - Society
Taiwanese fishing boat rescues crewmen from distressed freighter
01/16/2021 10:24 PM - Cross-Strait
Hon Hai to increase number of 'lighthouse' factories in China
01/16/2021 09:56 PM - Politics
Taiwan, U.S. diplomats meet after official contact ban lifted
01/16/2021 09:48 PM
